1
|
Essid R, Kefi S, Damergi B, Abid G, Fares N, Jallouli S, Abid I, Hussein D, Tabbene O, Limam F. Promising Antileishmanial Activity of Micromeria nervosa Essential Oil: In Vitro and In Silico Studies. Molecules 2024; 29:1876. [PMID: 38675696 PMCID: PMC11055018 DOI: 10.3390/molecules29081876] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2024] [Revised: 03/17/2024] [Accepted: 03/20/2024] [Indexed: 04/28/2024] Open
Abstract
The present study aimed to evaluate the leishmanicidal potential of the essential oil (EO) of Micromeria (M.) nervosa and to investigate its molecular mechanism of action by qPCR. Furthermore, in silicointeraction study of the major M. nervosa EO compounds with the enzyme cytochrome P450 sterol 14α-demethylase (CYP51) was also performed. M. nervosa EO was analyzed by gas chromatography-mass spectrometry (GC-MS). Results showed that α-pinene (26.44%), t-cadinol (26.27%), caryophyllene Oxide (7.73 ± 1.04%), and α-Cadinene (3.79 ± 0.12%) are the major compounds of M. nervosa EO. However, limited antioxidant activity was observed, as this EO was ineffective in neutralizing DPPH free radicals and in inhibiting β-carotene bleaching. Interestingly, it displayed effective leishmanicidal potential against promastigote (IC50 of 6.79 and 5.25 μg/mL) and amastigote (IC50 of 8.04 and 7.32 μg/mL) forms of leishmania (L.) infantum and L. major, respectively. Molecular mechanism investigation showed that M. nervosa EO displayed potent inhibition on the thiol regulatory pathway. Furthermore, a docking study of the main components of the EO with cytochrome P450 sterol 14α-demethylase (CYP51) enzyme revealed that t-cadinol exhibited the best binding energy values (-7.5 kcal/mol), followed by α-cadinene (-7.3 kcal/mol) and caryophyllene oxide (-7 kcal/mol). These values were notably higher than that of the conventional drug fluconazole showing weaker binding energy (-6.9 kcal/mol). These results suggest that M. nervosa EO could serve as a potent and promising candidate for the development of alternative antileishmanial agent in the treatment of leishmaniasis.
Collapse
Affiliation(s)
- Rym Essid
- Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP 901, Hammam-Lif 2050, Tunisia; (S.K.); (N.F.)
- University of Tunis-El Manar, Campus Universitaire Farhat Hached, BP-94 Rommana, Tunis 1068, Tunisia
| | - Sarra Kefi
- Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP 901, Hammam-Lif 2050, Tunisia; (S.K.); (N.F.)
- University of Tunis-El Manar, Campus Universitaire Farhat Hached, BP-94 Rommana, Tunis 1068, Tunisia
| | - Bilel Damergi
- Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP 901, Hammam-Lif 2050, Tunisia; (S.K.); (N.F.)
- University of Tunis-El Manar, Campus Universitaire Farhat Hached, BP-94 Rommana, Tunis 1068, Tunisia
| | - Ghassen Abid
- Laboratory of Legumes and Sustainable Agro-Systems, Centre of Biotechnology of Borj Cedria, Hammam-Lif 2050, Tunisia
| | - Nadia Fares
- Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP 901, Hammam-Lif 2050, Tunisia; (S.K.); (N.F.)
| | - Selim Jallouli
- Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP 901, Hammam-Lif 2050, Tunisia; (S.K.); (N.F.)
| | - Islem Abid
- Center of Excellence in Biotechnology Research, College of Applied Medical Sciences, King Saud University, Riyadh 11495, Saudi Arabia
| | - Dina Hussein
- Department of Chemistry, College of Sciences and Health, Cleveland State University, Cleveland, OH 44115, USA;
| | - Olfa Tabbene
- Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP 901, Hammam-Lif 2050, Tunisia; (S.K.); (N.F.)
| | - Ferid Limam
- Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP 901, Hammam-Lif 2050, Tunisia; (S.K.); (N.F.)
| |
Collapse
|
2
|
Lafi O, Essid R, Lachaud L, Jimenez C, Rodríguez J, Ageitos L, Mhamdi R, Abaza L. Synergistic antileishmanial activity of erythrodiol, uvaol, and oleanolic acid isolated from olive leaves of cv. Chemlali. 3 Biotech 2023; 13:395. [PMID: 37970450 PMCID: PMC10643720 DOI: 10.1007/s13205-023-03825-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2023] [Accepted: 10/17/2023] [Indexed: 11/17/2023] Open
Abstract
This study aimed to assess the antileishmanial activity of biomolecules obtained from Olea europaea L. leaves and twigs recovered from eight Tunisian cultivars. The extraction was first carried out with 80% methanol, and then the obtained extract was fractionated using three solvents of increasing polarity: cyclohexane (CHX), dichloromethane (DCM) and ethyl acetate (EtOAc). The antileishmanial activity was determined against leishmanial strains responsible for cutaneous, visceral, and mucocutaneous leishmaniasis. The cyclohexane fraction of the leaves of cv. Chemlali from the region of Sidi-Bouzid exhibited the strongest leishmanicidal activity against all the tested leishmanial strains. The inhibition concentrations (IC50) were 16.5, 14.5, and 7.4 μg mL-1 for Leishmania mexicana (cutaneous), Leishmania braziliensis (mucocutaneous), and Leishmania donovani (visceral), respectively. Interestingly, low cytotoxicity was observed on THP-1 cells with selective indexes (SI) ranging from 22.8 to 50.5. HPLC-HRMS and full-house NMR analysis allowed the identification of three triterpenic compounds, oleanolic acid (IC50 = 64.1 μg mL-1), erythrodiol (IC50 = 52.0 µg mL-1), and uvaol (IC50 = 53.8 μg mL-1). Antileishmanial activity of uvaol and oleanolic acid has been previously reported. However, this work constitutes the first report of the antileishmanial activity of erythrodiol which showed combinatorial interaction with uvaol (IC50 = 26.1 μg mL-1) against Leishmania tropica. The mixture of the three compounds, as major ones, exhibited an enhanced activity against Leishmania tropica (IC50 = 16.3 µg mL-1) compared to erythrodiol alone or the combination of uvaol and erythrodiol. This finding is of great importance and needs further investigation. Supplementary Information The online version contains supplementary material available at 10.1007/s13205-023-03825-3.
Collapse
Affiliation(s)
- Oumayma Lafi
- Laboratory of Biotechnology of Olive, Centre of Biotechnology of Borj Cedria, BP 901, 2050 Hammam-Lif, Tunisia
- Faculty of Mathematical, Physical and Natural Sciences of Tunis, The University of Tunis El Manar, 20 Street of Tolede, 2092 Tunis, Tunisia
| | - Rym Essid
- Laboratory of Bioactive Substances, Centre of Biotechnology of Borj Cedria, BP 901, 2050 Hammam-Lif, Tunisia
| | - Laurence Lachaud
- UMR, Univ Montpellier (IRD-CNRS), MIVEGEC, Montpellier, France
- Department of Parasitology-Mycology, CHU Montpellier, 39 Av. Charles Flahault, 34295 Montpellier cedex 5, France
| | - Carlos Jimenez
- CICA-Centro Interdisciplinar de Química e Bioloxía, Departamento de Química, Facultade de Ciencias, Universidade da Coruña, 15071 A Coruña, Spain
| | - Jaime Rodríguez
- CICA-Centro Interdisciplinar de Química e Bioloxía, Departamento de Química, Facultade de Ciencias, Universidade da Coruña, 15071 A Coruña, Spain
| | - Lucía Ageitos
- CICA-Centro Interdisciplinar de Química e Bioloxía, Departamento de Química, Facultade de Ciencias, Universidade da Coruña, 15071 A Coruña, Spain
| | - Ridha Mhamdi
- Laboratory of Biotechnology of Olive, Centre of Biotechnology of Borj Cedria, BP 901, 2050 Hammam-Lif, Tunisia
| | - Leila Abaza
- Laboratory of Biotechnology of Olive, Centre of Biotechnology of Borj Cedria, BP 901, 2050 Hammam-Lif, Tunisia
| |
Collapse
|
3
|
Ayed A, Essid R, Mankai H, Echmar A, Fares N, Hammami M, Sewald N, Limam F, Tabbene O. Synergistic antifungal activity and potential mechanism of action of a glycolipid-like compound produced by Streptomyces blastmyceticus S108 against Candida clinical isolates. J Appl Microbiol 2023; 134:lxad246. [PMID: 37884451 DOI: 10.1093/jambio/lxad246] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2022] [Revised: 09/04/2023] [Accepted: 10/25/2023] [Indexed: 10/28/2023]
Abstract
AIM The present study aimed to investigate a novel antifungal compound produced by Streptomyces blastmyceticus S108 strain. Its effectiveness against clinical isolates of Candida species and its synergistic effect with conventional antifungal drugs were assessed, and its molecular mechanism of action was further studied against Candida albicans. METHODS AND RESULTS A newly isolated strain from Tunisian soil, S. blastmyceticus S108, showed significant antifungal activity against Candida species by well diffusion method. The butanolic extract of S108 strain supernatant exhibited the best anti-Candida activity with a minimal inhibitory concentration (MIC) value of 250 μg ml-1, determined by the microdilution method. The bio-guided purification steps of the butanolic extract were performed by chromatographic techniques. Among the fractions obtained, F13 demonstrated the highest level of activity, displaying a MIC of 31.25 μg ml-1. Gas chromatography-mass spectrometry and electrospray ionization mass spectrometry analyses of this fraction (F13) revealed the glycolipidic nature of the active molecule with a molecular weight of 685.6 m/z. This antifungal metabolite remained stable to physicochemical changes and did not show hemolytic activity even at 4MIC corresponding to 125 µg ml-1 toward human erythrocytes. Besides, the glycolipid compound was combined with 5-flucytosine and showed a high synergistic effect with a fractional inhibitory concentration index value 0.14 against C. albicans ATCC 10231. This combination resulted in a decrease of MIC values of 5-flucytosine and the glycolipid-like compound by 8- and 64-fold, respectively. The examination of gene expression in treated C. albicans cells by quantitative polymerase chain reaction (qPCR) revealed that the active compound tested alone or in combination with 5-flucytosine blocks the ergosterol biosynthesis pathway by downregulating the expression of ERG1, ERG3, ERG5, ERG11, and ERG25 genes. CONCLUSION AND IMPACT OF THE STUDY The new glycolipid-like compound, produced by Streptomyces S108 isolate, could be a promising drug for medical use against pathogenic Candida isolates.
Collapse
Affiliation(s)
- A Ayed
- Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP 901, Hammam-Lif 2050, Tunisia
| | - R Essid
- Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP 901, Hammam-Lif 2050, Tunisia
| | - H Mankai
- Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP 901, Hammam-Lif 2050, Tunisia
| | - A Echmar
- Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP 901, Hammam-Lif 2050, Tunisia
| | - N Fares
- Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP 901, Hammam-Lif 2050, Tunisia
| | - M Hammami
- Laboratory of Aromatic and Medicinal Plants, Center of Biotechnology of Borj Cedria, Hammam-Lif 2050, Tunisia
| | - N Sewald
- Organic and Bioorganic Chemistry, Faculty of Chemistry, Bielefeld University, 33615 Bielefeld, Germany
| | - F Limam
- Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP 901, Hammam-Lif 2050, Tunisia
| | - O Tabbene
- Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP 901, Hammam-Lif 2050, Tunisia
| |
Collapse
|
4
|
Essid R, Damergi B, Fares N, Jallouli S, Limam F, Tabbene O. Synergistic combination of Cinnamomum verum and Syzygium aromaticum treatment for cutaneous leishmaniasis and investigation of their molecular mechanism of action. Int J Environ Health Res 2023:1-15. [PMID: 37855230 DOI: 10.1080/09603123.2023.2267470] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/09/2023] [Accepted: 10/02/2023] [Indexed: 10/20/2023]
Abstract
Combination therapy at appropriately suitable doses presents a promising alternative to monotherapeutic drugs. In this study, Cinnamomum verum and Syzygium aromaticum essential oils and their major compounds have exhibited substantial leishmaniacidal potential against both promastigote and amastigote forms of Leishmania (L.) major. However, they displayed high cytotoxicity against Raw264.7 macrophage cells. Interestingly, when combined with each other or with amphotericin B, they demonstrated a synergistic effect (FIC<0.5) with low cytotoxicity. These combinations are able to modulate the production of nitric oxide (NO) by macrophages. Notably, the combination of S. aromaticum Essential oil with amphotericin B stimulates macrophage cells by increasing NO production to eliminate leishmanial parasites. Furthermore, investigation of the molecular mechanism of action of these synergistic combinations reveals potent inhibition of the sterol pathway through the inhibition of the CYP51 gene expression. The findings suggest that combination therapy may offer significant therapeutic benefits in both food and pharmaceutical fields.
Collapse
Affiliation(s)
- Rym Essid
- Laboratory of Bioactive Substances, Biotechnology Center of Borj-Cedria Technopole, Hammam-Lif, Tunisia
| | - Bilel Damergi
- Laboratory of Bioactive Substances, Biotechnology Center of Borj-Cedria Technopole, Hammam-Lif, Tunisia
| | - Nadia Fares
- Laboratory of Bioactive Substances, Biotechnology Center of Borj-Cedria Technopole, Hammam-Lif, Tunisia
| | - Selim Jallouli
- Laboratory of Bioactive Substances, Biotechnology Center of Borj-Cedria Technopole, Hammam-Lif, Tunisia
| | - Ferid Limam
- Laboratory of Bioactive Substances, Biotechnology Center of Borj-Cedria Technopole, Hammam-Lif, Tunisia
| | - Olfa Tabbene
- Laboratory of Bioactive Substances, Biotechnology Center of Borj-Cedria Technopole, Hammam-Lif, Tunisia
| |
Collapse
|
5
|
Essid R, Ayed A, Djebali K, Saad H, Srasra M, Othmani Y, Fares N, Jallouli S, Abid I, Alothman MR, Limam F, Tabbene O. Anti-Candida and Anti-Leishmanial Activities of Encapsulated Cinnamomum verum Essential Oil in Chitosan Nanoparticles. Molecules 2023; 28:5681. [PMID: 37570651 PMCID: PMC10419485 DOI: 10.3390/molecules28155681] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2023] [Revised: 06/22/2023] [Accepted: 06/30/2023] [Indexed: 08/13/2023] Open
Abstract
Nanoencapsulation is widely considered as a highly effective strategy to enhance essential oils' (EO) stability by protecting them from oxidative deterioration and evaporation. The present study aims to optimize and characterize an efficient technique for encapsulating Cinnamomum (C.) verum essential oil into chitosan nanoparticles using response surface methodology (RSM). Moreover, the optimized C. verum EO nanoparticle was investigated for its antibacterial (against Gram-positive and Gram-negative bacteria), antifungal (against Candida albicans), and antiparasitic activity (against Leishmania parasites). Five parameters were investigated using a Plackett-Burman and Box-Behnken statistical design: the chitosan molecular weight, TPP concentration, C. verum EO/chitosan ratio, mixing method, and the duration of the reaction. Encapsulation efficiency and anti-candida activity were considered as responses. The antibacterial, anticandidal, and anti-leishmanial activities were also assessed using a standard micro-broth dilution assay and the cytotoxicity assay was assessed against the macrophage cell line RAW 264.7. The optimized nanoparticles were characterized using Fourier transform infrared spectroscopy, Zeta potential, and scanning electron microscopy. The study results indicated that under optimal conditions, the nanoencapsulation of C. verum EO into chitosan nanoparticles resulted in an encapsulation efficiency of 92.58%, with a regular distribution, a nanoparticle size of 480 ± 14.55 nm, and a favorable Zeta potential of 35.64 ± 1.37 mV. The optimized C. verum EO/chitosan nanoparticles showed strong antifungal activity against C. albicans pathogens (CMI = 125 µg mL-1), notable antibacterial activity against both Gram-positive and Gram-negative bacteria (ranging from 125 to 250 µg mL-1), high leishmanicidal potential against the promastigotes form of L. tropica and L. major (IC50 = 10.47 and 15.09 µg mL-1, respectively), and a four-fold cytotoxicity reduction compared to non-encapsulated essential oil. These results suggest that C. verum EO-loaded chitosan nanoparticles could be a promising delivery system for the treatment of cutaneous Candida albicans infections.
Collapse
Affiliation(s)
- Rym Essid
- Laboratoire des Substances Bioactives, Centre de Biotechnologie de Borj-Cedria, BP 901, Hammam-Lif 2050, Tunisia
| | - Ameni Ayed
- Laboratoire des Substances Bioactives, Centre de Biotechnologie de Borj-Cedria, BP 901, Hammam-Lif 2050, Tunisia
| | - Kais Djebali
- Valorization of Useful Material Laboratory (LVMU), National Research Center in Material Sciences (CNRSM) Technopôle Borj Cedria, BP 73, Soliman 8027, Tunisia
| | - Houda Saad
- Centre National en Recherche en Sciences des Matériaux, “CNRSM” Technopole Borj-Cedria-Route Touristique Soliman, BP-273, Soliman 8027, Tunisia
| | - Mondher Srasra
- Centre National en Recherche en Sciences des Matériaux, “CNRSM” Technopole Borj-Cedria-Route Touristique Soliman, BP-273, Soliman 8027, Tunisia
| | - Yasmine Othmani
- Laboratoire des Substances Bioactives, Centre de Biotechnologie de Borj-Cedria, BP 901, Hammam-Lif 2050, Tunisia
| | - Nadia Fares
- Laboratoire des Substances Bioactives, Centre de Biotechnologie de Borj-Cedria, BP 901, Hammam-Lif 2050, Tunisia
| | - Selim Jallouli
- Laboratoire des Substances Bioactives, Centre de Biotechnologie de Borj-Cedria, BP 901, Hammam-Lif 2050, Tunisia
| | - Islem Abid
- Department of Botany and Microbiology, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia
| | - Monerah Rashed Alothman
- Department of Botany and Microbiology, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia
| | - Ferid Limam
- Laboratoire des Substances Bioactives, Centre de Biotechnologie de Borj-Cedria, BP 901, Hammam-Lif 2050, Tunisia
| | - Olfa Tabbene
- Laboratoire des Substances Bioactives, Centre de Biotechnologie de Borj-Cedria, BP 901, Hammam-Lif 2050, Tunisia
| |
Collapse
|
6
|
Damergi B, Essid R, Fares N, Khadraoui N, Ageitos L, Ben Alaya A, Gharbi D, Abid I, Rashed Alothman M, Limam F, Rodríguez J, Jiménez C, Tabbene O. Datura stramonium Flowers as a Potential Natural Resource of Bioactive Molecules: Identification of Anti-Inflammatory Agents and Molecular Docking Analysis. Molecules 2023; 28:5195. [PMID: 37446858 DOI: 10.3390/molecules28135195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2023] [Revised: 06/01/2023] [Accepted: 06/12/2023] [Indexed: 07/15/2023] Open
Abstract
The present study investigated the antioxidant, antibacterial, antiviral and anti-inflammatory activities of different aerial parts (flowers, leaves and seeds) of Datura stramonium. The plant material was extracted with 80% methanol for about 24 h. The sensitivity to microorganisms analysis was performed by the microdilution technique. Antioxidant tests were performed by scavenging the DPPH and ABTS radicals, and by FRAP assay. Anti-inflammatory activity was evaluated through the inhibition of nitric oxide production in activated macrophage RAW 264.7 cells. Cell viability was assessed with an MTT assay. Results show that the flower extract revealed a powerful antimicrobial capacity against Gram-positive bacteria and strong antioxidant and anti-inflammatory activities. No significant cytotoxicity to activated macrophages was recorded. High resolution electrospray ionization mass spectrometry and nuclear magnetic resonance analysis identified two molecules with important anti-inflammatory effects: 12α-hydroxydaturametelin B and daturametelin B. Molecular docking analysis with both pro-inflammatory agents tumor necrosis factor alpha and interleukin-6 revealed that both compounds showed good binding features with the selected target proteins. Our results suggest that D. stramonium flower is a promising source of compounds with potential antioxidant, antibacterial, and anti-inflammatory activities. Isolated withanolide steroidal lactones from D. stramonium flower extract with promising anti-inflammatory activity have therapeutic potential against inflammatory disorders.
Collapse
Affiliation(s)
- Bilel Damergi
- Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP-901, Hammam-Lif 2050, Tunisia
- Faculty of Sciences of Tunis, University of Tunis El Manar, Tunis 2092, Tunisia
| | - Rym Essid
- Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP-901, Hammam-Lif 2050, Tunisia
| | - Nadia Fares
- Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP-901, Hammam-Lif 2050, Tunisia
| | - Nadine Khadraoui
- Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP-901, Hammam-Lif 2050, Tunisia
- Faculty of Sciences of Tunis, University of Tunis El Manar, Tunis 2092, Tunisia
| | - Lucía Ageitos
- Centro Interdisciplinar de Química e Bioloxía (CICA) and Departamento de Química, Facultade de Ciencias, Universidade da Coruña, 15071 Coruña, Spain
| | - Ameni Ben Alaya
- Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP-901, Hammam-Lif 2050, Tunisia
- Faculty of Sciences of Tunis, University of Tunis El Manar, Tunis 2092, Tunisia
| | - Dorra Gharbi
- Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP-901, Hammam-Lif 2050, Tunisia
| | - Islem Abid
- Botany and Microbiology Department, Science College, King Saud University, Riyadh 11451, Saudi Arabia
| | - Monerah Rashed Alothman
- Botany and Microbiology Department, Science College, King Saud University, Riyadh 11451, Saudi Arabia
| | - Ferid Limam
- Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP-901, Hammam-Lif 2050, Tunisia
| | - Jaime Rodríguez
- Centro Interdisciplinar de Química e Bioloxía (CICA) and Departamento de Química, Facultade de Ciencias, Universidade da Coruña, 15071 Coruña, Spain
| | - Carlos Jiménez
- Centro Interdisciplinar de Química e Bioloxía (CICA) and Departamento de Química, Facultade de Ciencias, Universidade da Coruña, 15071 Coruña, Spain
| | - Olfa Tabbene
- Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP-901, Hammam-Lif 2050, Tunisia
| |
Collapse
|
7
|
Rguez S, Aidi Wannes W, Bourgou S, Essid R, Bettaieb I, Snoussi M, Hammami M, Sellami IH. Sesquiterpenes from Pistacia lentiscus L. as potential antibacterial, antifungal and allelopathic agents. Journal of Essential Oil Research 2023. [DOI: 10.1080/10412905.2023.2196527] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/05/2023]
Affiliation(s)
- Safa Rguez
- Laboratory of Aromatic and Medicinal Plants, Center of Biotechnology of Borj Cedria, Hammam Lif, BP, Tunisia
| | - Wissem Aidi Wannes
- Laboratory of Aromatic and Medicinal Plants, Center of Biotechnology of Borj Cedria, Hammam Lif, BP, Tunisia
| | - Soumaya Bourgou
- Laboratory of Aromatic and Medicinal Plants, Center of Biotechnology of Borj Cedria, Hammam Lif, BP, Tunisia
| | - Rym Essid
- Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, Hammam Lif, BP, Tunisia
| | - Iness Bettaieb
- Laboratory of Aromatic and Medicinal Plants, Center of Biotechnology of Borj Cedria, Hammam Lif, BP, Tunisia
| | - Mejdi Snoussi
- Department of Biology, College of Science, University of Hai’l, Hai’l, Saudi Arabia
- Laboratory of Genetics, Biodiversity and Valorisation of Bioresources, High Institute of Biotechnology, University of Monastir 5000, Tunisia
| | - Majdi Hammami
- Laboratory of Aromatic and Medicinal Plants, Center of Biotechnology of Borj Cedria, Hammam Lif, BP, Tunisia
| | - Ibtissem Hamrouni Sellami
- Laboratory of Aromatic and Medicinal Plants, Center of Biotechnology of Borj Cedria, Hammam Lif, BP, Tunisia
| |
Collapse
|
8
|
Kefi S, Essid R, Papetti A, Abid G, Bouslama L, Aouani E, Tabbene O, Limam F. Antioxidant, antibacterial, and antileishmanial potential of Micromeria nervosa extracts and molecular mechanism of action of the bioactive compound. J Appl Microbiol 2023; 134:6989852. [PMID: 36649680 DOI: 10.1093/jambio/lxad007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2022] [Revised: 10/15/2022] [Accepted: 01/16/2023] [Indexed: 01/19/2023]
Abstract
AIMS This study aimed to determine the antibacterial and antileishmanial potential of Micromeria nervosa extracts. The identification of the antileishmanial compound and the study of its molecular mechanism of action have also been undertaken. METHODS AND RESULTS Ethanol extract showed high polyphenol content and diethyl ether extract exhibited high DPPH scavenging and low beta-carotene bleaching activity (IC50 = 13.04 ± 0.99 and 200.18 ± 3.32 μg mL-1, respectively). However, diethyl ether extract displayed high antibacterial activity against Gram-positive strains including methicillin-resistant Staphylococcus aureus (MIC = 31.25 μg mL-1), Staph. aureus ATCC6538 (MIC = 62.5 μg mL-1), and Listeria monocytogenes ATCC 19115 (MIC = 125 μg mL-1), as well as high antileishmanial activity against the promastigote forms of L. infantum and L. major (IC50 = 11.45 and 14.53 μg mL-1, respectively). The active compound was purified using bioassay-guided fractionation and thin layer chromatography, and identified as ursolic acid using high-performance liquid chromatography coupled with a photodiode array and mass spectrometry. The purified compound was strongly inhibitory against the promastigote and amastigote forms of L. infantum and L. major (IC50 = 5.87 and 6.95 μg mL-1 versus 9.56 and 10. 68 μg mL-1, respectively) without overt cytotoxicity against Raw 264.7 macrophage cells (SI = 13.53 and 11.43, respectively). The commercial compound (ursolic acid) showed similar activity against amastigotes and promastigotes forms of L. infantum and L. major. Moreover, its molecular mode of action against leishmaniasis seems to involve the expression of the ODC and SPS genes involved in thiol pathway. CONCLUSION Extracts of M. nervosa can be considered as a potential alternative to antimicrobial and antileishmanial drugs.
Collapse
Affiliation(s)
- Sarra Kefi
- Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP-901, 2050 Hammam-lif, Tunisia.,University of Tunis-El Manar, Campus Universitaire Farhat Hached, BP-94 Rommana, 1068 Tunis, Tunisia
| | - Rym Essid
- Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP-901, 2050 Hammam-lif, Tunisia.,University of Tunis-El Manar, Campus Universitaire Farhat Hached, BP-94 Rommana, 1068 Tunis, Tunisia
| | - Adele Papetti
- Laboratory of Nutraceutical and Food Chemical-Toxicological Analysis, Department of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy
| | - Ghassen Abid
- Laboratory of Legumes, Center of Biotechnology of Borj Cedria, BP-901, 2050 Hammam-lif, Tunisia
| | - Lamjed Bouslama
- Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP-901, 2050 Hammam-lif, Tunisia
| | - Ezzedine Aouani
- Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP-901, 2050 Hammam-lif, Tunisia.,Faculty of Sciences of Bizerte (FSB)-University of Carthage, 7021 Bizerte, Tunisia
| | - Olfa Tabbene
- Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP-901, 2050 Hammam-lif, Tunisia
| | - Ferid Limam
- Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP-901, 2050 Hammam-lif, Tunisia
| |
Collapse
|
9
|
Yacoub A, Ayadi A, Ayed W, Ayari S, Chebbi S, Magroun I, Ben Afia L, Mersni M, Mechergui N, Brahim D, Ben Said H, Bahri G, Youssef I, Ladhari N, Mziou N, Grassa A, M'rad M, Khessairi N, Krir A, Chihaoui M, Mahjoub S, Bahlous A, Jridi M, Cherif Y, Derbal S, Chebbi D, Hentati O, Ben Dahmen F, Abdallah M, Hamdi I, Sahli F, Ouerdani Y, Mnekbi Y, Abaza H, Ajmi M, Guedria A, Randaline A, Ben Abid H, Gaddour N, Maatouk A, Zemni I, Gara A, Kacem M, Maatouk I, Ben Fredj M, Abroug H, Ben Nasrallah C, Dhouib W, Bouanene I, Sriha A, Mahmoudi M, Gharbi G, Khsiba A, Azouz M, Ben Mohamed A, Yakoubi M, Medhioub M, Hamzaoui L, Azouz M, Ben Attig Y, Hamdi S, Essid R, Ben Jemia E, Rezgui B, Boudaya MS, Hassine H, Dabbabi H, Fradi Y, Cherif D, Lassoued I, Yacoub H, Kchir H, Maamouri N, Khairi W, Ben Ammar H, Abaza H, Chelbi E, Merhaben S, Neffati W, Ajmi M, Tarchalla S, Boughzala S, Gazzeh M, Gara S, Labidi A, Touati H, Nefzi AM, Ben Mustpha N, Fekih M, Serghini M, Boubaker J, Zouiten L, Driss A, Meddeb N, Driss I, Walha S, Ben Said H, Bel Hadj Mabrouk E, Zaimi Y, Mensi A, Trad N, Ayadi S, Said Y, Mouelhi L, Dabbèche R, Belfkih H, Bani M, Moussa A, Souissi S, Trabelsi Werchfeni B, Chelly S, Ezzi O, Ammar A, Besbes M, Njah M, Mahjoub M, Ghali H, Neffati A, Bhiri S, Bannour R, Ayadi S, Khouya FE, Kamel A, Hariz E, Aidani S, Kefacha S, Ben Cheikh A, Said H, Dogui S, Atig A, Gara A, Ezzar S, Ben Fradj M, Bouanène I, M'kadmi H, Farhati M, Dakhli N, Nalouti K, Chanoufi MB, Abouda SH, Louati C, Zaaimi Y, Dabbeche R, Hermi A, Saadi A, Mokaddem S, Boussaffa H, Bellali M, Zaghbib S, Ayed H, Bouzouita A, Derouiche A, Allouche M, Chakroun M, Ben Slama R, Gannoun N, Kacem I, Tlili G, Kahloul M, Belhadj Chabbah N, Douma F, Bouhoula M, Chouchene A, Aloui A, Maoua M, Brahem A, Kalboussi H, El Maalel O, Chatti S, Jaidane M, Naija W, Mrizek N, Sellami I, Feki A, Hrairi A, Kotti N, Baklouti S, Jmal Hammami K, Masmoudi ML, Hajjaji M, Naaroura A, Ben Amar J, Ouertani H, Ben Moussa O, Zaibi H, Aouina H, Ben Jemaa S, Gassara Z, Ezzeddine M, Kallel MH, Fourati H, Akrout R, Kallel H, Ayari M, Chehaider A, Souli F, Abdelaali I, Ziedi H, Boughzala C, Haouari W, Chelli M, Soltani M, Trabelsi H, Sahli H, Hamdaoui R, Masmoudi Y, Halouani A, Triki A, Ben Amor A, Makni C, Eloillaf M, Riahi S, Tlili R, Jmal L, Belhaj Ammar L, Nsibi S, Jmal A, Boukhzar R, Somai M, Daoud F, Rachdi I, Ben Dhaou B, Aydi Z, Boussema F, Frikha H, Hammami R, Ben Cheikh S, Chourabi S, Bokri E, Elloumi D, Hasni N, Hamza S, Berriche O, Dalhoum M, Jamoussi H, Kallel L, Mtira A, Sghaier Z, Ghezal MA, Fitouri S, Rhimi S, Omri N, Rouiss S, Soua A, Ben Slimene D, Mjendel I, Ferchichi I, Zmerli R, Belhadj Mabrouk E, Debbeche R, Makhloufi M, Chouchane A, Sridi C, Chelly F, Gaddour A, Kacem I, Chatti S, Mrizak N, Elloumi H, Debbabi H, Ben Azouz S, Marouani R, Cheikh I, Ben Said M, Kallel M, Amdouni A, Rejaibi N, Aouadi L, Zaouche K, Khouya FE, Aidani S, Khefacha S, Jelleli N, Sakly A, Zakhama W, Binous MY, Ben Said H, Bouallegue E, Jemmali S, Abcha S, Wahab H, Hmida A, Mabrouk I, Mabrouk M, Elleuch M, Mrad M, Ben Safta N, Medhioub A, Ghanem M, Boughoula K, Ben Slimane B, Ben Abdallah H, Bouali R, Bizid S, Abdelli MN, Ben Nejma Y, Bellakhal S, Antit S, Bourguiba R, Zakhama L, Douggui MH, Bahloul E, Dhouib F, Turki H, Sabbah M, Baghdadi S, Trad D, Bellil N, Bibani N, Elloumi H, Gargouri D, Ben Said M, Hamdaoui R, Chokri R, Kacem M, Ben Rejeb M, Miladi A, Kooli J, Touati S, Trabelsi S, Klila M, Rejeb H, Kammoun H, Akrout I, Greb D, Ben Abdelghaffar H, Hassene H, Fekih L, Smadhi H, Megdiche MA, Ksouri J, Kasdalli H, Hayder A, Gattoussi M, Chérif L, Ben Saida F, Gueldich M, Ben Jemaa H, Dammak A, Frikha I, Saidani A, Ben Amar J, Aissi W, Chatti AB, Naceur I, Ben Achour T, Said F, Khanfir M, Lamloum M, Ben Ghorbel I, Houman M, Cherif T, Ben Mansour A, Daghfous H, Slim A, Ben Saad S, Tritar F, Naffeti W, Abdellatif J, Ben Fredj M, Selmi M, Kbir GH, Maatouk M, Jedidi L, Taamallah F, Ben Moussa M, Halouani L, Rejeb S, Khalffalah N, Ben Ammar J, Hedhli S, Azouz MM, Chatti S, Athimni Z, Bouhoula M, Elmaalel O, Mrizak N, Maalej M, Kammoun R, Gargouri F, Sallemi S, Haddar A, Masmoudi K, Oussaifi A, Sahli A, Bhouri M, Hmaissi R, Friha M, Cherif H, Baya C, Triki M, Yangui F, Charfi MR, Ben Hamida HY, Karoui S, Aouini F, Hajlaoui A, Jlassi H, Sabbah M, Fendri MN, Kammoun N, Fehri S, Nouagui H, Harzalli A, Snène H, Belakhal S, Ben Hassine L, Labbene I, Jouini M, Kalboussi S, Ayedi Y, Harizi C, Skhiri A, Fakhfakh R, Jelleli B, Belkahla A, Fejjeri M, Zeddini M, Mahjoub S, Nouira M, Frih N, Debiche S, Blibech H, Belhaj S, Mehiri N, Ben Salah N, Louzir B, Kooli J, Bahri R, Chaka A, Abdenneji S, Majdoub Fehri S, Hammadi J, Dorgham D, Hriz N, Kwas H, Issaoui N, Jaafoura S, Bellali H, Shimi M, Belhaj Mabrouk E, Sellami R, Ketata I, Medi W, Mahjoub M, Ben Yacoub S, Ben Chaabene A, Touil E, Ben Ayed H, Ben Miled S, El Zine E, Khouni H, Ben Kadhi S, Maatoug J, Boulma R, Rezgui R, Boudokhane M, Jomni T, Chamekh S, Aissa S, Touhiri E, Jlaiel N, Oueslati B, Maaroufi N, Aouadi S, Belkhir S, Daghfous H, Merhaben S, Dhaouadi N, Ounaes Y, Chaker K, Yaich S, Marrak M, Bibi M, Mrad Dali K, Sellami A, Nouira Y, Sellami S, Anane I, Trabelsi H, Ennaifer R, Benzarti Z, Bouchabou B, Hemdani N, Nakhli A, Cherif Y, Abdelkef M, Derbel K, Barkous B, Yahiaoui A, Sayhi A, Guezguez F, Rouatbi S, Racil H, Ksouri C, Znegui T, Maazaoui S, Touil A, Habibech S, Chaouech N, Ben Hmid O, Ismail S, Chouaieb H, Chatti M, Guediri N, Belhadj Mohamed M, Bennasrallah C, Bouzid Y, Zaouali F, Toumia M, El Khemiri N, El Khemiri A, Sfar H, Farhati S, Ben Chehida F, Yamoun R, Braham N, Hamdi Y, Ben Mansour A, Mtir M, Ayari M, Toumia M, Rouis S, Sakly H, Nakhli R, Ben Garouia H, Chebil D, Hannachi H, Merzougui L, Samet S, Hrairi A, Mnif I, Hentati O, Bouzgarrou L, Souissi D, Boujdaria R, Kadoussi R, Rejeb H, Ben Limem I, Ben Salah I, Greb D, Ben Abdelghaffar H, Smadhi H, Laatiri H, Manoubi SA, Gharbaoui M, Hmandi O, Zhioua M, Taboubi F, Hamza Y, Hannach W, Jaziri H, Gharbi R, Hammami A, Dahmani W, Ben Ameur W, Ksiaa M, Ben Slama A, Brahem A, Elleuch N, Jmaa A, Kort I, Jlass S, Benabderrahim S, Turki E, Belhaj A, Kebsi D, Ben Khelil M, Rmadi N, Gamaoun H, Alaya Youzbechi F, Brahim T, Boujnah S, Abid N, Gader N, Kalboussi S, Ben Sassi S, Loukil M, Ghrairi H, Ben Said N, Mrad O, Ferjaoui M, Hedhli L, Ben Kaab B, Berriche A, Charfi R, Mourali O, Smichi I, Bel Haj Kacem L, Ksentini M, Aloui R, Ferchichi L, Nasraoui H, Maoua M, Chérif F, Belil Y, Ayed MA, Alloulou Y, Belhadj S, Daghfous J, Mehiri N, Louzir B, Abbes A, Ghrab A, Chermiti A, Akacha A, Mejri O, Debbiche A, Yahiaoui C, Binous M, Tissaoui A, Mekni K, El Fekih C, Said MA, Chtioui S, Mestiri S, Smaoui H, Ben Hamida S, Haddar A, Mrizek N, Gares N, Zaibi A, Bouazizi N, Gallas S, Lachhab A, Belhadj M, Hadj Salem N, Garrouch A, Mezgar Z, Khrouf M, Abbassi H, Souissi D, Hamra I, Ben Mustapha N, Abessi I, Boubaker F, Bouchareb S, ElOmma Mrabet H, Touil I, Boussoffara L, Knani J, Boudawara N, Alaya W, Sfar MH, Fekih S, Snène H, Boudawara N, Gargouri I, Benzarti W, Knaz A, Abdelghani A, Aissa S, Hayouni A, Mejri I, Kacem M, Mhamdi S, Daboussi S, Aichaouia C, Moatemri Z, Chaachou A, Fsili R, Ben Ghezala H, Ben Jazia A, Brahmi N. 2022 TUNISIAN NATIONAL CONGRESS OF MEDICINE ABSTRACTS. Tunis Med 2023; 101:62-64. [PMID: 37682263] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Subscribe] [Scholar Register] [Received: 01/09/2023] [Indexed: 09/09/2023]
|
10
|
Agougui C, Cecilia JA, Saad H, Franco-Duro F, Essid R, Khabbouchi M, Frini-Srasra N. Adsorption of Carvone and Limonene from Caraway essential oil onto Tunisian montmorillonite clay for pharmaceutical application. Sci Rep 2022; 12:19814. [PMID: 36396702 PMCID: PMC9672104 DOI: 10.1038/s41598-022-24268-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2022] [Accepted: 11/14/2022] [Indexed: 11/18/2022] Open
Abstract
To explore a novel kind of green composite material having excellent antibacterial, antifungal ability and specific-targeting capability for pharmaceutical uses, a novel kind of bio-composite was prepared using sodium purified clay as carrier of Caraway essential oil (CEO). Gas chromatography-mass spectroscopy (GC-MS) analyses of CEO reveals that Carvone (68.30%) and Limonene (22.54%) are the two major components with a minimum inhibitory concentration (MIC) value equal to 125 mg/mL against Staphylococcus (S) aureus bacteria and Candida albicans fungi. Clay from Zaghouan was purified and characterized by X-ray Photoelectron Spectroscopy (XPS), X-ray diffraction (XRD), Fourier transformed infrared spectroscopy (FT-IR) and N2 adsorption-desorption (BET method). Results obtained by chromatograph equipped with a flame ionization detector (GC-FID) show that the concentration of 130 mg/mL of essential oil and 5 h of contact with the purified clay are the optimal conditions for the bio-hybrid formation. The pseudo-second-order model can describe the kinetic study of the adsorption of Carvone and Limonene on sodium montmorillonite, and the adsorption isotherms have been established to the Langmuir type. Limonene registers a maximum adsorption value equal to 3.05 mg/g of clay however Carvone register the higher amount of adsorption (19.98 mg/g) according to its polarity and the abundance of this compound in the crude CEO. X-ray diffraction, Fourier transformed infrared spectroscopy, elemental analyses (CHN) and X-ray fluorescence characterization valid the success adsorption of CEO in sodium montmorillonite surface. The purified clay/CEO hybrid (purified clay/CEO) combined the advantages of both the clay and the essential oil used in exerting the antibacterial and antifungal activity, and thus, the composite has a double antibacterial and antifungal activity compared to the separately uses of inactive clay and CEO, suggesting the great potential application in pharmaceutical treatments.
Collapse
Affiliation(s)
- Chaima Agougui
- grid.12574.350000000122959819Faculty of Sciences of Tunis (FST), Tunis El Manar University, Campus Universitaire Tunis El Manar, 2092 Tunis, Tunisia ,Laboratory of Composite Materials and Clay Minerals, National Center of Materials Research, Borj Cedria Technopole, Tunis, Tunisia
| | - Juan Antonio Cecilia
- grid.10215.370000 0001 2298 7828Department of Inorganic Chemistry, Crystallography and Mineralogy, Universidad de Málaga, Campus de Teatinos, 29071 Malaga, Spain
| | - Houda Saad
- Laboratory of Composite Materials and Clay Minerals, National Center of Materials Research, Borj Cedria Technopole, Tunis, Tunisia
| | - Francisco Franco-Duro
- grid.10215.370000 0001 2298 7828Department of Inorganic Chemistry, Crystallography and Mineralogy, Universidad de Málaga, Campus de Teatinos, 29071 Malaga, Spain
| | - Rym Essid
- Laboratory of Bioactive Substances, Biotechnologie Center, Borj Cedria Technopole, Tunis, Tunisia
| | - Mohamed Khabbouchi
- grid.12574.350000000122959819Faculty of Sciences of Tunis (FST), Tunis El Manar University, Campus Universitaire Tunis El Manar, 2092 Tunis, Tunisia ,Laboratory of Composite Materials and Clay Minerals, National Center of Materials Research, Borj Cedria Technopole, Tunis, Tunisia
| | - Najoua Frini-Srasra
- grid.12574.350000000122959819Faculty of Sciences of Tunis (FST), Tunis El Manar University, Campus Universitaire Tunis El Manar, 2092 Tunis, Tunisia ,Laboratory of Composite Materials and Clay Minerals, National Center of Materials Research, Borj Cedria Technopole, Tunis, Tunisia
| |
Collapse
|
11
|
Khadraoui N, Essid R, Jallouli S, Damergi B, Ben Takfa I, Abid G, Jedidi I, Bachali A, Ayed A, Limam F, Tabbene O. Antibacterial and antibiofilm activity of Peganum harmala seed extract against multidrug-resistant Pseudomonas aeruginosa pathogenic isolates and molecular mechanism of action. Arch Microbiol 2022; 204:133. [PMID: 34999965 DOI: 10.1007/s00203-021-02747-z] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2021] [Revised: 12/24/2021] [Accepted: 12/27/2021] [Indexed: 12/21/2022]
Abstract
Biofilm formation of the opportunistic pathogen Pseudomonas (P). aeruginosa is one of the major global challenges to control nosocomial infections due to their high resistance to antimicrobials and host defense mechanisms. The present study aimed to assess the antibacterial and the antibiofilm activities of Peganum (P). harmala seed extract against multidrug-resistant P. aeruginosa isolates. Chemical identification of the active compound and determination of its molecular mechanism of action were also investigated. Results showed that P. harmala n-butanol "n-BuOH" extract exhibited antibacterial activity against multidrug-resistant P. aeruginosa isolates. This extract was even more active than conventional antibiotics cefazolin and vaamox when tested against three P. aeruginosa multidrug-resistant isolates. In addition, P. harmala n-BuOH extract exhibited potent bactericidal activity against PAO1 strain at MIC value corresponding to 500 µg/mL and attained 100% killing effect at 24 h of incubation. Furthermore, P. harmala n-BuOH extract showed an antibiofilm activity against P. aeruginosa PAO1 and exhibited 80.43% inhibition at sub-inhibitory concentration. The extract also eradicated 83.99% of the biofilm-forming bacteria. The active compound was identified by gas chromatography-mass spectrometry as an indole alkaloid harmaline. Transcriptomic analysis showed complete inhibition of the biofilm-related gene pilA when PAO1 cells were treated with harmaline. Our results revealed that P. harmala seed extract and its active compound harmaline could be considered as a candidate for a new treatment of multidrug-resistant P. aeruginosa pathogens-associated biofilm infections.
Collapse
Affiliation(s)
- Nadine Khadraoui
- Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP-901, 2050, Hammam-Lif, Tunisia
- Faculty of Sciences of Tunis, University of Tunis El Manar, 2092, Tunis, Tunisia
| | - Rym Essid
- Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP-901, 2050, Hammam-Lif, Tunisia
| | - Selim Jallouli
- Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP-901, 2050, Hammam-Lif, Tunisia
| | - Bilel Damergi
- Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP-901, 2050, Hammam-Lif, Tunisia
- Faculty of Sciences of Tunis, University of Tunis El Manar, 2092, Tunis, Tunisia
| | - Iheb Ben Takfa
- Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP-901, 2050, Hammam-Lif, Tunisia
| | - Ghassen Abid
- Laboratory of Legumes and Sustainable Agrosystems, Biotechnology Center of Borj Cedria, BP-901, 2050, Hammam-Lif, Tunisia
| | - Ines Jedidi
- Water and Food Control Laboratory, National Center of Salmonella, Shigella, Vibrio-Enteropathogens-Pasteur Institute of Tunis-Belvédère, Tunis, Tunisia
| | - Asma Bachali
- Laboratory of Clinical Biochemistry, Mohamed Taher Maamouri Hospital, Nabeul, Tunisia
| | - Ameni Ayed
- Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP-901, 2050, Hammam-Lif, Tunisia
| | - Ferid Limam
- Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP-901, 2050, Hammam-Lif, Tunisia
| | - Olfa Tabbene
- Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP-901, 2050, Hammam-Lif, Tunisia.
| |
Collapse
|
12
|
Hammi KM, Essid R, Khadraoui N, Ksouri R, Majdoub H, Tabbene O. Antimicrobial, antioxidant and antileishmanial activities of Ziziphus lotus leaves. Arch Microbiol 2022; 204:119. [PMID: 34989872 DOI: 10.1007/s00203-021-02733-5] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2021] [Revised: 12/04/2021] [Accepted: 12/17/2021] [Indexed: 11/28/2022]
Abstract
The aim of this study was to investigate antimicrobial and antioxidant activities of different fractions obtained from edible Tunisian Ziziphus Lotus leaves of Tozeur region. Different organic extracts were tested: cyclohexane, dichloromethane, ethyl acetate, n-butanol and water. Bio-guided fractionation revealed that dichloromethane fraction is the most active against S. aureus and Methicillin-resistant S. aureus strains. Moreover, this fraction showed the highest antileishmanial activity with IC50 values of 20.55 ± 0.34 μg/mL and 15.37 ± 0.17 μg/mL against L. major and L. infantum, respectively. The potentialities of antibacterial and leishmanicidal activities found in dichloromethane could be explained by the presence of major flavonoids such as catechin, rutin and luteolin 7-O-glucoside as revealed by HPLC system. The observed moderate antifungal activity, which was only given by butanolic fraction against pathogen fungi, may be attributed to the presence of chlorogenic acid. Furthermore, dichloromethane and butanolic fraction showed a good DPPH (2,2-diphenyl-1-picryl hydrazyl) scavenging activity and Ferric reducing power. These results suggest that Ziziphus lotus leaf fractions might be used as antioxidant and antimicrobialagent.
Collapse
Affiliation(s)
- Khaoula Mkadmini Hammi
- Laboratoire des Plantes Aromatiques et Médicinales (LPAM), Centre de Biotechnologie de Borj-Cédria, BP 901, 2050, Hammam-Lif, Tunisia.,Laboratoire des Interfaces et des Matériaux Avancés (LIMA), Faculté des Sciences de Monastir, Université de Monastir, Bd. de l'environnement, 5019, Monastir, Tunisia
| | - Rym Essid
- Laboratoire des Substances Bioactives, Centre de Biotechnologie de Borj-Cédria, BP 901, 2050, Hammam-Lif, Tunisia.
| | - Nadine Khadraoui
- Laboratoire des Substances Bioactives, Centre de Biotechnologie de Borj-Cédria, BP 901, 2050, Hammam-Lif, Tunisia
| | - Riadh Ksouri
- Laboratoire des Plantes Aromatiques et Médicinales (LPAM), Centre de Biotechnologie de Borj-Cédria, BP 901, 2050, Hammam-Lif, Tunisia
| | - Hatem Majdoub
- Laboratoire des Interfaces et des Matériaux Avancés (LIMA), Faculté des Sciences de Monastir, Université de Monastir, Bd. de l'environnement, 5019, Monastir, Tunisia
| | - Olfa Tabbene
- Laboratoire des Substances Bioactives, Centre de Biotechnologie de Borj-Cédria, BP 901, 2050, Hammam-Lif, Tunisia
| |
Collapse
|
13
|
Soussi S, Essid R, Karkouch I, Saad H, Bachkouel S, Aouani E, Limam F, Tabbene O. Effect of Lipopeptide-Loaded Chitosan Nanoparticles on Candida albicans Adhesion and on the Growth of Leishmania major. Appl Biochem Biotechnol 2021; 193:3732-3752. [PMID: 34398423 DOI: 10.1007/s12010-021-03621-w] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2021] [Accepted: 07/12/2021] [Indexed: 01/12/2023]
Abstract
Cyclic lipopeptides produced by Bacillus species exhibit interesting therapeutic potential. However, their clinical use remains limited due to their low stability, undesirable interactions with host macromolecules, and their potential toxicity to mammalian cells. The present work aims to develop suitable lipopeptide-loaded chitosan nanoparticles with improved biological properties and reduced toxicity. Surfactin and bacillomycin D lipopeptides produced by Bacillus amyloliquefaciens B84 strain were loaded onto chitosan nanoparticles by ionotropic gelation process. Nanoformulated lipopeptides exhibit an average size of 569 nm, a zeta potential range of 38.8 mV, and encapsulation efficiency (EE) of 85.58%. Treatment of Candida (C.) albicans cells with encapsulated lipopeptides induced anti-adhesive activity of 81.17% and decreased cell surface hydrophobicity (CSH) by 25.53% at 2000 µg/mL. Nanoformulated lipopeptides also induced antileishmanial activity against Leishmania (L.) major promastigote and amastigote forms at respective IC50 values of 14.37 µg/mL and 22.45 µg/mL. Nanoencapsulated lipopeptides exerted low cytotoxicity towards human erythrocytes and Raw 264.7 macrophage cell line with respective HC50 and LC50 values of 770 µg/mL and 234.56 µg/mL. Nanoencapsulated lipopeptides could be used as a potential delivery system of lipopeptides to improve their anti-adhesive effect against C. albicans cells colonizing medical devices and their anti-infectious activity against leishmania.
Collapse
Affiliation(s)
- Siwar Soussi
- Laboratoire Des Substances Bioactives, Centre de Biotechnologie de Borj-Cedria (CBBC), BP-901, 2050, Hammam-lif, Tunisia.,Faculté Des Sciences de Bizerte, Université de Carthage, Tunis, Tunisia
| | - Rym Essid
- Laboratoire Des Substances Bioactives, Centre de Biotechnologie de Borj-Cedria (CBBC), BP-901, 2050, Hammam-lif, Tunisia
| | - Ines Karkouch
- Laboratoire Des Substances Bioactives, Centre de Biotechnologie de Borj-Cedria (CBBC), BP-901, 2050, Hammam-lif, Tunisia
| | - Houda Saad
- Laboratoire Des Matériaux Composites Et Minéraux Argileux, Centre National Des Recherches en Sciences Des Matériaux, BP-73, 8027, Soliman, Tunisia
| | - Sarra Bachkouel
- Centre de Biotechnologie de Borj-Cedria (CBBC), Espace D'Appui À La Recherche Et de Transfert Technologique, BP-901, 2050, Hammam-lif, Tunisia
| | - Ezzedine Aouani
- Laboratoire Des Substances Bioactives, Centre de Biotechnologie de Borj-Cedria (CBBC), BP-901, 2050, Hammam-lif, Tunisia
| | - Ferid Limam
- Laboratoire Des Substances Bioactives, Centre de Biotechnologie de Borj-Cedria (CBBC), BP-901, 2050, Hammam-lif, Tunisia
| | - Olfa Tabbene
- Laboratoire Des Substances Bioactives, Centre de Biotechnologie de Borj-Cedria (CBBC), BP-901, 2050, Hammam-lif, Tunisia.
| |
Collapse
|
14
|
Soussi S, Essid R, Hardouin J, Gharbi D, Elkahoui S, Tabbene O, Cosette P, Jouenne T, Limam F. Utilization of Grape Seed Flour for Antimicrobial Lipopeptide Production by Bacillus amyloliquefaciens C5 Strain. Appl Biochem Biotechnol 2019; 187:1460-1474. [PMID: 30251231 DOI: 10.1007/s12010-018-2885-1] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2018] [Accepted: 09/10/2018] [Indexed: 10/28/2022]
Abstract
An endophytic Bacillus amyloliquefaciens strain called C5, able to produce biosurfactant lipopeptides with a broad antibacterial activity spectrum, has been isolated from the roots of olive tree. Optimization of antibacterial activity was undertaken using grape seed flour (GSF) substrate at 0.02, 0.2, and 2% (w/v) in M9 medium. Strain C5 exhibited optimal growth and antimicrobial activity (MIC value of 60 μg/ml) when incubated in the presence of 0.2% GSF while lipopeptide production culminated at 2% GSF. Thin layer chromatography analysis of lipopeptide extract revealed the presence of at least three active spots at Rf 0.35, 0.59, and 0.72 at 0.2% GSF. Data were similar to those obtained in LB-rich medium. MALDI-TOF/MS analysis of lipopeptide extract obtained from 0.2% GSF substrate revealed the presence of surfactin and bacillomycin D. These results show that GSF could be used as a low-cost culture medium supplement for optimizing the production of biosurfactants by strain C5.
Collapse
Affiliation(s)
- Siwar Soussi
- Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP-901, 2050, Hammam-lif, Tunisia.,University of Carthage, Avenue de la République, BP-77, 1054, Amilcar, Tunisia
| | - Rym Essid
- Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP-901, 2050, Hammam-lif, Tunisia
| | - Julie Hardouin
- Polymers, Biopolymers, Surface Laboratory, UMR 6270 CNRS, Normandie University, Mont-Saint-Aignan, France.,Proteomic Platform PISSARO, 76821, Mont-Saint-Aignan, France
| | - Dorra Gharbi
- Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP-901, 2050, Hammam-lif, Tunisia.,University of Carthage, Avenue de la République, BP-77, 1054, Amilcar, Tunisia
| | - Salem Elkahoui
- Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP-901, 2050, Hammam-lif, Tunisia
| | - Olfa Tabbene
- Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP-901, 2050, Hammam-lif, Tunisia
| | - Pascal Cosette
- Polymers, Biopolymers, Surface Laboratory, UMR 6270 CNRS, Normandie University, Mont-Saint-Aignan, France.,Proteomic Platform PISSARO, 76821, Mont-Saint-Aignan, France
| | - Thierry Jouenne
- Polymers, Biopolymers, Surface Laboratory, UMR 6270 CNRS, Normandie University, Mont-Saint-Aignan, France.,Proteomic Platform PISSARO, 76821, Mont-Saint-Aignan, France
| | - Ferid Limam
- Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP-901, 2050, Hammam-lif, Tunisia.
| |
Collapse
|
15
|
Medjeldi S, Bouslama L, Benabdallah A, Essid R, Haou S, Elkahoui S. Biological activities, and phytocompounds of northwest Algeria Ajuga iva (L) extracts: Partial identification of the antibacterial fraction. Microb Pathog 2018; 121:173-178. [PMID: 29775724 DOI: 10.1016/j.micpath.2018.05.022] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2018] [Revised: 04/30/2018] [Accepted: 05/14/2018] [Indexed: 10/16/2022]
Abstract
The use of synthetic food additive and the appearance of antibiotic resistance are at the basis of important human health problems. The substitution of synthetic compounds with new natural substances extracted from plants or microorganisms is therefore the ideal solution to this scourge. The objective of this work was to evaluate the phyto-constituents (polyphenols, flavonoids and condensed tannins), and to test the biological activities (antioxidant, antibacterial and antiviral) of the Ajuga iva (L) aerial part extracts. The antioxidant activity assayed by DPPH method showed an IC50 of 0.43 ± 0.03 mg/mL. Antibacterial activity of aqueous and hydro methalonic extracts was tested against seven pathogenic bacteria (Staphylococcus aureus, Methicillin Resistant Staphylococcus aureus (MRS), Listeria monocytogenes, Pseudomonas aeruginosa, Bacillus cereus, Escherichia coli and Salmonella enteritidis) using the diffusion method. A Thin Layer Chromatography-bioautotography-guided was performed, and the isolated antibacterial fraction was identified by CG-MS analysis. Antiviral effect of methanolic extract performed on 4 viruses: Coxsackie Virus type B-3 (CVB-3), Adenovirus type 5 (ADV-5), Respiratory Syncytial Virus type B (RSV-B) and Herpes Simplex Virus type 2 (HSV-2) showed an activity against Coxsackie Virus. As a result of this study, the aerial parts of Ajuga iva (L) extract could be used in the food, cosmetic, medical and health sectors.
Collapse
Affiliation(s)
- Saida Medjeldi
- SAPVESA Laboratory, Faculty of Life and Natural Sciences, University of Chadli Bendjedid, BP 73, El-Tarf, 36000, Algeria; Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP 901, Hammam Lif, 2050, Tunisia.
| | - Lamjed Bouslama
- Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP 901, Hammam Lif, 2050, Tunisia
| | - Amina Benabdallah
- SAPVESA Laboratory, Faculty of Life and Natural Sciences, University of Chadli Bendjedid, BP 73, El-Tarf, 36000, Algeria
| | - Rym Essid
- Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP 901, Hammam Lif, 2050, Tunisia
| | - Soumaya Haou
- SAPVESA Laboratory, Faculty of Life and Natural Sciences, University of Chadli Bendjedid, BP 73, El-Tarf, 36000, Algeria
| | - Salem Elkahoui
- Laboratory of Bioactive Substances, Biotechnology Center of Borj Cedria, BP 901, Hammam Lif, 2050, Tunisia
| |
Collapse
|
16
|
Kefi S, Essid R, Mkadmini K, Kefi A, Mahjoub Haddada F, Tabbene O, Limam F. Phytochemical investigation and biological activities of Echium arenarium (Guss) extracts. Microb Pathog 2018; 118:202-210. [DOI: 10.1016/j.micpath.2018.02.050] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2017] [Revised: 01/26/2018] [Accepted: 02/23/2018] [Indexed: 12/15/2022]
|
17
|
Chelbi H, Essid R, Jelassi R, Bouzekri N, Zidi I, Ben Salah H, Mrad I, Ben Sghaier I, Abdelmalek R, Aissa S, Bouratbine A, Aoun K. High-resolution melting-curve (HRM) analysis for C. meleagridis identification in stool samples. Microb Pathog 2018; 115:332-337. [DOI: 10.1016/j.micpath.2017.12.070] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2017] [Revised: 12/22/2017] [Accepted: 12/28/2017] [Indexed: 10/18/2022]
|
18
|
Essid R, Menotti J, Hanen C, Aoun K, Bouratbine A. Genetic diversity of Cryptosporidium isolates from human populations in an urban area of Northern Tunisia. Infect Genet Evol 2018; 58:237-242. [PMID: 29320719 DOI: 10.1016/j.meegid.2018.01.004] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/23/2017] [Revised: 01/05/2018] [Accepted: 01/06/2018] [Indexed: 10/18/2022]
Abstract
Cryptosporidium is an enteric parasite infecting a wide range of hosts. It has emerged as an important cause of chronic life-threatening diarrhea in humans worldwide. Several subtypes of Cryptosporidium sp. have been described to be responsible for several large outbreaks related to water contamination in developed countries. However, there is a lack of information in the genetic diversity of Cryptosporidium among human population especially in developing countries. The present study aimed to update and report the genetic diversity of human Cryptosporidium spp. at the subtype level in an urban area of Tunisia using the 18S rRNA and gp60 gene. Genotyping of 42 Cryptosporidium positive isolates from different human populations at the 18S rRNA locus has identified three Cryptosporidium species: C. hominis (n = 20), C. parvum (n = 19), C. meleagridis (n = 2) and a co-infection C. hominis/C. meleagridis (n = 1). The sub-genotyping of these isolates at the 60-kda glycoprotein (gp60) locus was possible in 40 cases. It showed the presence of three subtype families (IIa, IIb and IIc) within C. parvum, a single subtype family within C. hominis and C. meleagridis isolates (Ia and IIIb respectively). Several subtypes were implicated in different human populations with the dominance of IaA26G1R1, IIaA15G2R1, IIdA16G1R1, IIdA22G2R1 and IIIbA26G1R1 variant respectively for C. hominis, C. parvum and C. meleagridis. The distribution of Cryptosporidium isolates in urban area of Northern Tunisia was dominated by the anthroponotic transmission via C. hominis species and the IIc subtype of C. parvum. However, zoonotic transmission is still possible in this region via zoonotic subtypes of C. parvum (IIa and IId) and C. meleagridis (IIIb). Subtype diversity was higher in this area.
Collapse
Affiliation(s)
- Rym Essid
- Laboratoire de Parasitologie-Mycologie, LR, 11-IPT-06, Institut Pasteur de Tunis, 13 place Pasteur, 1002, Tunis, Tunisia.
| | - Jean Menotti
- Laboratoire de Parasitologie-Mycologie, Institut des Agents Infectieux, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Université Claude Bernard - Lyon 1, EA 7426, Lyon, France
| | - Chelbi Hanen
- Laboratoire de Parasitologie-Mycologie, LR, 11-IPT-06, Institut Pasteur de Tunis, 13 place Pasteur, 1002, Tunis, Tunisia
| | - Karim Aoun
- Laboratoire de Parasitologie-Mycologie, LR, 11-IPT-06, Institut Pasteur de Tunis, 13 place Pasteur, 1002, Tunis, Tunisia
| | - Aïda Bouratbine
- Laboratoire de Parasitologie-Mycologie, LR, 11-IPT-06, Institut Pasteur de Tunis, 13 place Pasteur, 1002, Tunis, Tunisia
| |
Collapse
|
19
|
Ramdane F, Essid R, Fares N, El Ouassis D, Aziz S, Mahammed MH, Ould Hadj MD, Limam F. Antioxidant antileishmanial cytotoxic and antimicrobial activities of a local plant Myrtus nivellei from Algeria Sahara. Asian Pac J Trop Biomed 2017. [DOI: 10.1016/j.apjtb.2017.07.011] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
20
|
Abstract
Cryptosporidium spp. are a major cause of gastrointestinal diseases in humans worldwide. While a single subtype of Cryptosporidium hominis has been shown to be responsible for several large outbreaks related to water contamination in developed countries, little is known about the epidemiology of C. hominis in developing countries. This study reports the first genetic characterization of C. hominis at the subtype level in several human populations in Tunisia using the gp60 gene. Eighteen isolates were identified as C. hominis by a restriction fragment length polymorphism (RFLP) analysis. The prevalence of this species in different human populations ranges from 1.53% to 13.04% with a high prevalence being reported in immunocompromised children (13.04%) followed by patients with malignent myeloma (5.5%) and HIV-infected patients (4.59%). The gp60 analysis on C. hominis isolates, performed in 14 cases, showed the presence of a single subtype family: "Ia". Different subtypes were identified within this family (A11G1R1, A12R3, A23G1R1, A26G1R1, A27G1R1, A28G1R1). The IaA26G1R1 subtype was the most dominant subtype described in this area (50%). Despite the high genetic diversity of Cryptosporidium spp, a low heterogeneity at the subtype level was observed within C. hominis circulating in Tunisia. This distribution is an indicator for intensive and stable anthroponotic cryptosporidiosis in this region. Besides, the presence of a unique genotype in 5 HIV-infected patients attending the same hospital ward suggests the possible occurrence of hospital-acquired infection and underlines the need to implement preventive measures to avoid nosocomial transmission.
Collapse
Affiliation(s)
- Rym Essid
- Laboratoire de Parasitologie-Mycologie, LR 11-IPT-06, Institut Pasteur de Tunis, 13 Place Pasteur, 1002 Tunis, Tunisia.
| | - Hanen Chelbi
- Laboratoire de Parasitologie-Mycologie, LR 11-IPT-06, Institut Pasteur de Tunis, 13 Place Pasteur, 1002 Tunis, Tunisia
| | - Emna Siala
- Laboratoire de Parasitologie-Mycologie, LR 11-IPT-06, Institut Pasteur de Tunis, 13 Place Pasteur, 1002 Tunis, Tunisia
| | - Ines Bensghair
- Laboratoire de Parasitologie-Mycologie, LR 11-IPT-06, Institut Pasteur de Tunis, 13 Place Pasteur, 1002 Tunis, Tunisia
| | - Jean Menotti
- Laboratoire de Parasitologie-Mycologie, Hôpital Saint-Louis, AP-HP / Université Paris Diderot, Sorbonne, Paris Cité, 75010 Paris, France
| | - Aïda Bouratbine
- Laboratoire de Parasitologie-Mycologie, LR 11-IPT-06, Institut Pasteur de Tunis, 13 Place Pasteur, 1002 Tunis, Tunisia
| |
Collapse
|
21
|
Ramdane F, Essid R, Mkadmini K, Hammami M, Fares N, Mahammed MH, El Ouassis D, Tabbene O, Limam F, Ould Hadj MD. Phytochemical composition and biological activities of Asteriscus graveolens (Forssk) extracts. Process Biochem 2017. [DOI: 10.1016/j.procbio.2017.03.004] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
|
22
|
Siala E, Essid R, Smiri M, Doggui A, Ben Sghaier I, Aoun K, Bouratbine A. Contribution of Polymerase Chain Reaction for detection of malaria in Tunisia. Tunis Med 2015; 93:766-770. [PMID: 27249386] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
BACKGROUND In Tunisia, detection of Plasmodium in asymptomatic individuals from endemic countries is a critical measure in national program of malaria eradication. The screening is based on microscopic examination of thick and thin blood smears. However, the performance of this diagnosis is closely related to the experience of biologist and the parasitaemia. AIM The objective of this study was to evaluate the contribution of the PCR in the screening of malaria. METHODS This prospective study involved 260 students from malaria endemic areas who were screened for malaria between september 2011 and june 2013. Each subject had a blood sample which was examined for malaria by microscopy and nested multiplex PCR. RESULTS PCR detected the presence of Plasmodium in 13 blood samples (5%). While microscopy was positive only in nine cases (3.5%). The discordances involved five negative samples at microscopy and which were positive in PCR and a negative sample in PCR which was positive at microscopy. A mixed infection with Plasmodium falciparum and Plasmodium malariae was identified by PCR. For this case, microscopy diagnosed only Plasmodium falciparum specie. CONCLUSION PCR is more efficient than microscopy in detecting low parasitaemia ; particularly observed in asymptomatic subjects. This technique allows to reduce asymptomatic carriage of Plasmodium and reduce the risk of a resumption of transmission of malaria in our country.
Collapse
|
23
|
Siala E, Gastli M, Essid R, Jemal S, Ben Abdallah R, Ben Abda I, Aoun K, Bouratbine A. Late relapse of imported Plasmodium ovale malaria: a case report. Tunis Med 2015; 93:347-349. [PMID: 26644094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
We report the first case of an imported Plasmodium ovale relapse in a Tunisian man who developed malaria three years after leaving sub- Saharan Africa. A 29-year-old Tunisian man consulted in September 2011 because of a fever, myalgia, and headache that had begun eight days earlier and persisted despite treatment with oral antibiotics. On questioning, the patient stated that he had resided three years ago for six months in Ivory Coast, where he acquired malaria. He was treated with artemether-lumefantrine. The patient said he had no recent travel to any other malaria-endemic area and had not received a blood transfusion. A first microscopy of peripheral blood smears was negative for malaria parasites. The diagnosis was established 17 days after onset of symptoms. A repeat microscopic examination of blood smears confirmed the presence of Plasmodium ovale with a parasitemia lower than 0.1%. The patient was treated with artemether lumefantrine, followed by primaquine. This case emphasizes the possibility of relapse of some plasmodial species. It highlights the importance of repeating microscopic examination of blood when the diagnosis of malaria is suspected.
Collapse
|
24
|
Elkahoui S, Djébali N, Yaich N, Azaiez S, Hammami M, Essid R, Limam F. Antifungal activity of volatile compounds-producing Pseudomonas P2 strain against Rhizoctonia solani. World J Microbiol Biotechnol 2014; 31:175-85. [PMID: 25384611 DOI: 10.1007/s11274-014-1772-3] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2014] [Accepted: 11/03/2014] [Indexed: 11/25/2022]
Abstract
Several volatile organic compounds (VOCs) producing endophyte bacteria were isolated from the leaves of olive trees and tested for their antifungal activity against several pathogenic fungi. An antagonistic strain called P2 showed 97 % of homology with Pseudomonas sp. strains on the basis of its 16S rDNA sequence and biochemical properties. P2 strain drastically inhibited the growth of Rhizoctonia solani mycelia (86 %) at 5 day-post-confrontation (dpc) and strongly reduced fungi infection on potato slices at 10(7) bacteria ml(-1) for 3 and 7 dpc. P2 strain was also positive for protease activity as well as siderophore production. Light microscopy analysis showed that treatment of R. solani mycelia with P2 strain induced thickening of the cell-wall, vesiculation of protoplasm and blockage of fungal hyphae branching. VOCs analysis using GC-MS allowed the detection of two major products with m/z of 93.9910 and 125.9630 corresponding to dimethyl disulfide and dimethyl trisulfide respectively. VOCs-producing P2 strain could be a promising agent in the protection of tuber crops against fungal diseases.
Collapse
Affiliation(s)
- Salem Elkahoui
- Laboratoire des Substances Bioactives, Centre de Biotechnologie de Borj-Cédria, BP-901, 2050, Hammam-Lif, Tunisia
| | | | | | | | | | | | | |
Collapse
|
25
|
Rahmouni I, Essid R, Aoun K, Bouratbine A. Glycoprotein 60 diversity in Cryptosporidium parvum causing human and cattle cryptosporidiosis in the rural region of Northern Tunisia. Am J Trop Med Hyg 2013; 90:346-50. [PMID: 24343888 DOI: 10.4269/ajtmh.13-0522] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
The zoonotic potential of Cryptosporidium parvum was studied in an extensive cattle farming region of northern Tunisia. Seventy fecal samples from pre-weaning calves and 403 fecal samples from children were examined by microscopy after modified Ziehl-Neelsen (MZN) staining. Positive Cryptosporidium specimens were identified at a species level using an 18S rRNA nested polymerase chain reaction (PCR) followed by an Restriction Fragment Length Polymorphism (RFLP) analysis. C. parvum isolates were subgenotyped by sequence analysis of the glycoprotein 60 (gp60) gene. Among calf samples, 14 samples were positive by MZN method. C. parvum was identified in all cases. Twelve parvum isolates (85.7%) belonged to family subtype IIa. Subtype IIaA15G2R1 was more prevalent (50%). Two C. parvum isolates corresponded to the IIdA16G1 subtype. Seven human samples were positive by MZN method. C. parvum and C. meleagridis were identified in four and three cases, respectively. Intraspecific characterization of C. parvum identified two subtypes, the IIaA15G2R1 and the IIdA16G1, also found in calves.
Collapse
Affiliation(s)
- Ikram Rahmouni
- Laboratoire de Parasitologie-Mycologie, Institut Pasteur de Tunis, Tunis, Tunisia
| | | | | | | |
Collapse
|
26
|
Boughattas S, Bergaoui R, Essid R, Aoun K, Bouratbine A. Seroprevalence of Toxoplasma gondii infection among horses in Tunisia. Parasit Vectors 2011; 4:218. [PMID: 22107730 PMCID: PMC3253060 DOI: 10.1186/1756-3305-4-218] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2011] [Accepted: 11/22/2011] [Indexed: 11/10/2022] Open
Abstract
Background The present study was conducted to investigate the serological survey of Toxoplasma antibodies in local.horses from three major regions: a neighbourhood of a city in the North (Sidi Thabet), a neighbourhood of a city on the coast (Monastir) and a neighbourhood of a city in the middle (Battan) of Tunisia (North of Africa). Methods A total of 158 serum samples were obtained from clinically healthy horses which consisted of 111 (32 female, 79 male) 2-10 years old and 47 (11 female, 36 male) older than 10 years. All of the horses were tested for antibodies to T. gondii using the Modified Agglutination Test (MAT). Results According to MAT results, antibodies to T. gondii were found in 28 (17.7%) of 158 sera with the titers of 1:20 in 20 horses, 1:40 in 1 horse, 1:80 in 2 horses, 1:160 in 2 horses, 1:320 in 1 horse and ≥1:640 in 2 horses. Anti-T. gondii antibodies were found in 18 (16.2%) of 111 horses (2-10 years old) and 10 (21.2%) of 47 horses (older than 10 years old). Six (13.9%) out of 43 female had anti-toxoplasma antibodies and 22 (19.1%) from 115 males remained positive. Conclusion Statistically significant differences in age groups and genders were observed between the seropositive and seronegative horses using the Chi square X(2) test. Other statistical correlation was also reported concerning horse breed.
Collapse
Affiliation(s)
- Sonia Boughattas
- Laboratoire de Recherche 05SP03, Laboratoire de Parasitologie, Institut Pasteur de Tunis, 13 Place Pasteur BP74, 1002 Tunis Belvédères, Tunisia
| | | | | | | | | |
Collapse
|
27
|
Ben Abda I, Essid R, Mellouli F, Aoun K, Bejaoui M, Bouratbine A. [Cryptosporidium infection in patients with major histocompatibility complex class II deficiency syndrome in Tunisia: description of five cases]. Arch Pediatr 2011; 18:939-44. [PMID: 21816586 DOI: 10.1016/j.arcped.2011.06.015] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2010] [Revised: 05/11/2011] [Accepted: 06/24/2011] [Indexed: 10/17/2022]
Abstract
BACKGROUND In Tunisia, Cryptosporidium is frequently identified in diarrheic stools of children and immunocompromised patients. The infection is usually self-limited in immunocompetent populations, but can be severe and life-threatening in immunocompromised individuals. Cryptosporidiosis is well-documented in patients with the human immunodeficiency virus; however, few data are available concerning children with primary immunodeficiencies (PIDs). PATIENTS AND METHODS A retrospective study was conducted on 5 cryptosporidiosis cases diagnosed in 11 children with PIDs. Cryptosporidium was systematically investigated when patients presented chronic diarrhea. Stool samples were examined for the parasite oocysts by modified Ziehl-Neelsen staining, and DNA was systematically extracted for a nested polymerase chain reaction (PCR). The species were identified by the analysis of restriction patterns. Epidemiological and clinicobiological data were presented for each patient. RESULTS All cryptosporidiosis cases presented a CMH class II deficiency syndrome. Chronic diarrhea was associated with failure to thrive in all cases. PCR provided the diagnosis in all patients, while Ziehl-Neelsen staining revealed Cryptosporidium oocysts in only 3 cases. Species identification yielded Cryptosporidium hominis in 2 cases, Cryptosporidium meleagridis in 1 case, and Cryptosporidium parvum in 1 case; a C. hominis/C. meleagridis co-infection was observed in the last case. C. hominis was isolated in children from rural areas, suggesting that the infection could have been contracted in the hospital and thus a probability of nosocomial transmission. One of the C. hominis carriers developed sclerosing cholangitis with a high parasite load. CONCLUSION Cryptosporidiosis with serious clinical symptoms is observed in PID patients, particularly those with CMH class II deficiency syndrome. Early, regular, and repeated screening, improved by PCR, is recommended in this group of patients. The predominance of C. hominis, the anthropophilic species, in children from rural areas should emphasize hygiene measures in care centers where PID cases are treated.
Collapse
Affiliation(s)
- I Ben Abda
- Laboratoire de parasitologie-mycologie laboratoire de recherche 05SP03, institut Pasteur de Tunis, 13, place Pasteur, 1002 Tunis, Tunisie
| | | | | | | | | | | |
Collapse
|
28
|
Abdelmalek R, Anane S, Chabchoub N, Essid R, Aoun K, Chaabéne TB, Bouratbine A. Co-infection par des microsporidies et des cryptosporidies chez un nouveau-né infecté par le VIH. Arch Pediatr 2011; 18:562-4. [DOI: 10.1016/j.arcped.2011.02.016] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2010] [Revised: 09/09/2010] [Accepted: 02/20/2011] [Indexed: 10/28/2022]
|
29
|
Essid R, Mousli M, Aoun K, Abdelmalek R, Mellouli F, Kanoun F, Derouin F, Bouratbine A. Identification of cryptosporidium species infecting humans in Tunisia. Am J Trop Med Hyg 2008; 79:702-705. [PMID: 18981507] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/27/2023] Open
Abstract
Prevalence and species distribution of Cryptosporidium spp. were determined among 633 immunocompetent children less than five years of age and 75 patients hospitalized for immunodeficiency who lived in northern Tunisia. Microscopy was used for initial screening to detect positive samples and a nested polymerase chain reaction and restriction fragment length polymorphism analysis was used to determine the species. Cryptosporidium spp. was identified in 2.7% of cases (19 stool samples), and there was a significant difference between samples collected from immunocompromised patients and those collected from healthy children (10.7% versus 1.7%). Prevalence was also significantly higher in diarrheal specimens than in formed specimens (6.3% versus 1.6%). Cryptosporidium hominis and C. parvum were responsible for most Cryptosporidium spp. infections (78.9%). Cryptosporidium hominis was more prevalent in children from urban areas than in those from rural areas, and C. parvum was found with similar prevalence rates in the two populations. Cryptosporidium meleagridis was identified in four children on farms.
Collapse
Affiliation(s)
- Rym Essid
- Laboratoire de Recherche 05SP03, Laboratoire de Parasitologie et Laboratoire d'Immunologie-Vaccinologie-Genetique Moléculaire, Institut Pasteur de Tunis, Tunis, Tunisia
| | | | | | | | | | | | | | | |
Collapse
|
30
|
Essid R, Mousli M, Aoun K, Mellouli F, Kanoun F, Abdelmalek R, Derouin F, Bouratbine A. Identification of Cryptosporidium Species Infecting Humans in Tunisia. Am J Trop Med Hyg 2008. [DOI: 10.4269/ajtmh.2008.79.702] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
31
|
Regaya F, Khelifa R, Zouari R, Kchir M, Karoui M, Essid R. [Research on Parvovirus B19 infections and chronic articular manifestations in a Tunisian hospital]. Arch Inst Pasteur Tunis 2003; 80:9-15. [PMID: 15941063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/02/2023]
Abstract
Parvovirus B19 infection is often associated with acute and chronic joint diseases thus suggesting an etiologic role for the virus in these pathologies. In this work, we looked for a possible correlation between Parvovirus B19 infection and certain types of chronic inflammatory rheumatisms. We therefore, screened a population of 100 patients with different chronic inflammatory rheumatismal affections for serological markers of Parvovirus B19 infection. All patients were Tunisians of both sexes, who presented at the service of Rheumatology of the Charles Nicolle Hospital, Tunis. One hundred blood donors were taken as controls. Specific Immunoenzyme Assays of the ELISA type (Biotrin International, France) were used to detect anti-Parvovirus IgG and IgM. On the other hand, viral DNA was sought by nested PCR in synovial fluid from 14 patients. The data obtained indicate that specific anti-Parvovirus B19 IgG was detectable in the sera of 80.7% of patients and 43% of controls. In contrast, none of the sera was found positive for specific IgM antibodies. Synovial fluid samples could be collected from 14 anti-Parvovirus B19 seropositive patients and were tested for the presence of viral DNA. None of the samples was found positive. The results of our serological study reinforce the hypothesis that Parvovirus B19 infection is associated with rheumatismal joint affections. However, the lack of detectable viral DNA in synovial fluid of the tested seropositive patients points to an indirect role of the virus in these joint disorders.
Collapse
Affiliation(s)
- F Regaya
- Banque du sang, Hôpital Charles Nicolle a Tunis
| | | | | | | | | | | |
Collapse
|